First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-016-4055-x
Published Online: 2016-11-17
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Altundag, Kadri
License valid from 2016-11-17
